150 related articles for article (PubMed ID: 22424788)
1. Long-term changes in morphology, D2R expression and targets of regenerated dopaminergic terminals in the striatum after a partial lesion in the substantia nigra in the rat.
Zeng X; Shen H; Zhao J; Cai Q; Wang C; Xu Q
Brain Res; 2012 Apr; 1450():166-73. PubMed ID: 22424788
[TBL] [Abstract][Full Text] [Related]
2. Glial responses associated with dopaminergic striatal reinnervation following lesions of the rat substantia nigra.
Stanic D; Tripanichkul W; Drago J; Finkelstein DI; Horne MK
Brain Res; 2004 Oct; 1023(1):83-91. PubMed ID: 15364022
[TBL] [Abstract][Full Text] [Related]
3. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
[TBL] [Abstract][Full Text] [Related]
4. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
Rosenblad C; Kirik D; Björklund A
Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
[TBL] [Abstract][Full Text] [Related]
5. Timecourse of striatal re-innervation following lesions of dopaminergic SNpc neurons of the rat.
Stanic D; Finkelstein DI; Bourke DW; Drago J; Horne MK
Eur J Neurosci; 2003 Sep; 18(5):1175-88. PubMed ID: 12956716
[TBL] [Abstract][Full Text] [Related]
6. Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 1. Dopaminergic neurons and receptors.
Yokoyama C; Okamura H
J Pharmacol Exp Ther; 1997 Feb; 280(2):1016-30. PubMed ID: 9023319
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and immunocytochemical changes induced by intrastriatal 6-hydroxydopamine injection in the rat nigrostriatal dopamine neuron system: evidence for cell death in the substantia nigra.
Ichitani Y; Okamura H; Nakahara D; Nagatsu I; Ibata Y
Exp Neurol; 1994 Dec; 130(2):269-78. PubMed ID: 7867756
[TBL] [Abstract][Full Text] [Related]
9. Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver staining.
Ares-Santos S; Granado N; Espadas I; Martinez-Murillo R; Moratalla R
Neuropsychopharmacology; 2014 Apr; 39(5):1066-80. PubMed ID: 24169803
[TBL] [Abstract][Full Text] [Related]
10. Prooxidant properties of ascorbic acid in the nigrostriatal dopaminergic system of C57BL/6 mice.
Kang MJ; Lee SS; Koh HC
Toxicology; 2012 Mar; 294(1):1-8. PubMed ID: 22285708
[TBL] [Abstract][Full Text] [Related]
11. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
[TBL] [Abstract][Full Text] [Related]
12. The role of dopamine receptors in regulating the size of axonal arbors.
Parish CL; Finkelstein DI; Drago J; Borrelli E; Horne MK
J Neurosci; 2001 Jul; 21(14):5147-57. PubMed ID: 11438590
[TBL] [Abstract][Full Text] [Related]
13. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
[TBL] [Abstract][Full Text] [Related]
14. Substantia nigra 6-hydroxydopamine lesions alter dopaminergic synaptic markers in the nucleus basalis magnocellularis and striatum of rats.
Geula C; Slevin JT
Synapse; 1989; 4(3):248-53. PubMed ID: 2532792
[TBL] [Abstract][Full Text] [Related]
15. Changes in function and ultrastructure of striatal dopaminergic terminals that regenerate following partial lesions of the SNpc.
Stanic D; Parish CL; Zhu WM; Krstew EV; Lawrence AJ; Drago J; Finkelstein DI; Horne MK
J Neurochem; 2003 Jul; 86(2):329-43. PubMed ID: 12871574
[TBL] [Abstract][Full Text] [Related]
16. D2 Dopamine receptor blockade results in sprouting of DA axons in the intact animal but prevents sprouting following nigral lesions.
Tripanichkul W; Stanic D; Drago J; Finkelstein DI; Horne MK
Eur J Neurosci; 2003 Mar; 17(5):1033-45. PubMed ID: 12653979
[TBL] [Abstract][Full Text] [Related]
17. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigra.
Blanchard V; Anglade P; Dziewczapolski G; Savasta M; Agid Y; Raisman-Vozari R
Brain Res; 1996 Feb; 709(2):319-25. PubMed ID: 8833770
[TBL] [Abstract][Full Text] [Related]
19. Regulation of GAP-43 protein and mRNA in nigrostriatal dopaminergic neurons after the partial destruction of dopaminergic terminals with intrastriatal 6-hydroxydopamine.
Iwata SI; Nomoto M; Fukuda T
Synapse; 2001 Jan; 39(1):16-22. PubMed ID: 11071705
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of L-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats.
Yamada H; Aimi Y; Nagatsu I; Taki K; Kudo M; Arai R
Neurosci Res; 2007 Sep; 59(1):1-7. PubMed ID: 17586078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
